Consensus EirGenix Inc.

Equities

6589

TW0006589005

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
83.1 ^TWD	+2.34%		+4.01%	-17.31%

Mar. 22	EirGenix Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 08	EirGenix, Inc. Resolves to Sign the Contract with Clinical CRO and the Relevant Companies for Phase III Clinical Trail of the EG1206A	CI

Evolution of the average Target Price on EirGenix Inc.

Price target over the last 5 years

History of analyst recommendation changes

0113606b590679dea4a5206d39c36f6f.Hz5gR0FU133qBAtL2SiQuBn3HCMKshs2eHKb6xPzTMU.Wn8kPioxpympbGBysxuo1WiAeA5ZhnZcLj62nXu7FZx1alMMETCgNphQYA~c7194e1f5234518472f0c1aa8bdb6b9f